MYOPIA AND PRESBYOPIA TREATMENT MARKET ANALYSIS

Regional Analysis

Global Myopia and Presbyopia Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global myopia and presbyopia market over the forecast period, owing to increasing government approvals for the treatment of myopia. For instance, On March 2, 2022, Johnson & Johnson Vision, an eye health company , announced that the U.S. Food and Drug Administration (FDA) has approved ACUVUE Theravision with Ketotifen (etafilcon A drug-eluting contact lens with ketotifen). Each lens contains 19 mcg ketotifen. Ketotifen is a well-established antihistamine. ACUVUE Theravision with Ketotifen is the first in an entirely new category of contact lenses and brings forward a new wearing experience for contact lens wearers with allergic eye itch. Ketotifen are daily disposable contact lenses recommended for patients who do not have red eyes, who are suitable for contact lens wear, and who do not have more than 1.00 D of astigmatism to correct vision and prevent ocular itching due to allergic conjunctivitis.              

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa